ArticleCancer research2008

Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.

Heiko Konig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.